Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (501-510 of 959) with videos related to

Pageof 96
Sort By:
Respiratory Medicine|July 29, 2018
Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trialPhilippe Devillier, Marc Humbert, Alain Boye, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2004
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertensionOlivier Sitbon, Virginie Gressin, Rudolf Speich, et al.
The European Respiratory Journal|November 28, 2019
Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertensionAthénaïs Boucly, Capucine Morélot-Panzini, Gilles Garcia, et al.
The European Respiratory Journal|July 25, 2015
Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot studySwanny Perrin, David Montani, Caroline O'Connell, et al.
The European Respiratory Journal|June 13, 2020
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitorsJason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, et al.
Lancet (London, England)|December 10, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 studyDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
The European Respiratory Journal|November 11, 2017
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implicationsAndrea Olschewski, Emma L Veale, Bence M Nagy, et al.
The Journal of Clinical Investigation|February 7, 2009
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodentsMohamed Izikki, Christophe Guignabert, Elie Fadel, et al.
The European Respiratory Journal|January 28, 2012
Pregnancy outcomes in pulmonary arterial hypertension in the modern management eraXavier Jaïs, Karen M Olsson, Joan A Barbera, et al.
JCI Insight|February 8, 2019
Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantationNatalia F Smirnova, Thomas M Conlon, Carmela Morrone, et al.
Pageof 96

Showing results (501-510 of 959) with videos related to

Sort By:
Pageof 96
Respiratory Medicine|July 29, 2018
Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trialPhilippe Devillier, Marc Humbert, Alain Boye, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2004
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertensionOlivier Sitbon, Virginie Gressin, Rudolf Speich, et al.
The European Respiratory Journal|November 28, 2019
Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertensionAthénaïs Boucly, Capucine Morélot-Panzini, Gilles Garcia, et al.
The European Respiratory Journal|July 25, 2015
Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot studySwanny Perrin, David Montani, Caroline O'Connell, et al.
The European Respiratory Journal|June 13, 2020
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitorsJason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, et al.
Lancet (London, England)|December 10, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 studyDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
The European Respiratory Journal|November 11, 2017
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implicationsAndrea Olschewski, Emma L Veale, Bence M Nagy, et al.
The Journal of Clinical Investigation|February 7, 2009
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodentsMohamed Izikki, Christophe Guignabert, Elie Fadel, et al.
The European Respiratory Journal|January 28, 2012
Pregnancy outcomes in pulmonary arterial hypertension in the modern management eraXavier Jaïs, Karen M Olsson, Joan A Barbera, et al.
JCI Insight|February 8, 2019
Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantationNatalia F Smirnova, Thomas M Conlon, Carmela Morrone, et al.
Pageof 96